Chinese Journal of Magnetic Resonance ›› 2023, Vol. 40 ›› Issue (1): 1-9.doi: 10.11938/cjmr20222995

• Articles • Previous Articles     Next Articles

Structure Characterization and Analgesic Activity of Novel Pyrazolo[3,4-d]pyrimidin-4-one Derivatives

ZHAI Chonggang1,2,WANG Pengcheng1,2,SHAN Yubao1,2,LAN Yu3,#(),HU Rui1,2,*(),YANG Yunhuang1,2   

  1. 1. CAS Key Laboratory of Magnetic Resonance in Biological System, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan 430071, China
    2. University of Chinese Academy of Sciences, Beijing 100049, China
    3. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China
  • Received:2022-04-07 Published:2023-03-05 Online:2022-05-12
  • Contact: LAN Yu,HU Rui E-mail:lanthane@whu.edu.cn.;hurui@wipm.ac.cn

Abstract:

Three compounds of novel pyrazolo[3,4-d]pyrimidin-4-one derivatives (A~C) were synthesized through a multi-step reaction using ethyl-2-cyano-3-ethoxyacrylate and 3,4-dimethylphenylhydrazine. The structures of these compounds were identified by nuclear magnetic resonance (NMR, i.e., 1H NMR, 13C NMR), and liquid chromatography-mass spectrum (LC-MS), and the 1H NMR signals of each compound were fully assigned. The in vivo analgesic activity of synthesized compound A was preliminarily evaluated through mass spectrometry brain imaging and formalin induced pain model in mice. The imaging data and results showed that compound A could cross the blood-brain barrier and penetrate into the brain of mice, and produce a dose-dependent analgesic activity. This study provided a piece of fundamental research data on structural and in vivo activity for developing anti-pain drugs based on pyrazolo[3,4-d]pyrimidin-4-one scaffold.

Key words: pyrazolo[3,4-d]pyrimidin-4-one, 1H NMR, 13C NMR, mass spectrometry imaging, analgesic activity

CLC Number: